Kemula Pierre Thadee Victor bought AGMB

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002119332-26-000001

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 6, 2026

Published

Oct 7, 2026

Ingested by INSIDER

Nov 5, 02:12 UTC

Last re-read

Nov 5, 02:12 UTC

Extracted facts

Filer

Kemula Pierre Thadee Victor

Role

Chief Financial Officer

Transaction

Open-market purchaseAs filed: “P”

Asset

AgomAb Therapeutics NV

Ticker

AGMB

Shares

2,000

Price per share

$8.54

Value

$17,080

Execution date (reported)

Oct 6, 2026

Owned after transaction

10.0K shares

Days from execution to publication

1

Calculation

What this establishes

Kemula Pierre Thadee Victor filed this Form 4 reporting a open-market purchase of AGMB on Oct 6, 2026. It became public on Oct 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Kemula Pierre Thadee Victorcik:0002119332

Issuer

AgomAb Therapeutics NVcik:0002020932

Revision history · 0

No field has changed since this record was first ingested.